Joy A. Pai

机构：Enzo Life Sciences (United States), Calico Life Sciences · ORCID：0000-0003-3580-8061

发表论文 33 篇 · 总被引 3460 次 · h-index 21

代表论文

• Combination therapy with anti-HIV-1 antibodies maintains viral suppression (2018 · Nature · 被引 554)
• High-throughput and single-cell T cell receptor sequencing technologies (2021 · Nature Methods · 被引 303)
• Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals (2018 · Nature Medicine · 被引 265)
• KIR + CD8 + T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19 (2022 · Science · 被引 250)
• Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques (2019 · Nature · 被引 203)
• Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade (2023 · Cancer Cell · 被引 153)